Usefulness of Acupuncture in Cancer Pain and Quality of Life
NCT ID: NCT00401063
Last Updated: 2013-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2006-09-30
2007-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer
NCT03505671
Acupuncture to Improve Quality of Life in Patients With Advanced Cancer
NCT00070967
Effect of Acupuncture for QoL in Gastric Cancer Patients Undergoing Adjuvant Chemotherapy: a Pilot Study
NCT03753399
Acupuncture for Shortness of Breath in Cancer Patients
NCT00067691
Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial
NCT00200096
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single arm
Acupuncture treatment
Acupuncture
Acupuncture treatment twice a day for eight weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acupuncture
Acupuncture treatment twice a day for eight weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age of 18 or older
* Baseline pain score of 3 or above on 0-10 rating scale
* In the evaluation of the treating physician or medically-qualified investigator, the patient's pain syndrome is the result of underlying cancer or cancer treatment
* Being ambulatory
* Permission from the treating physician (MD/oncologist)
* Platelet count of 50,000 or greater
Exclusion Criteria
* Neutropenia defined as ANC (absolute neutrophil count) \< 1000/ml
* Inability to obtain permission from the treating physician
* Unwillingness to sign informed consent form
* Involvement in litigation
* Simultaneous infection with HIV or Hepatitis C virus
* Unable to present for follow up
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Southern California University of Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sivarama Vinjamury
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sivarama P Vinjamury, MD, MAOM
Role: PRINCIPAL_INVESTIGATOR
Southern California University of Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Health Center
Pasadena, California, United States
Southern California University of Health Sciences
Whittier, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Visit Southern California University of Health Sciences Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SCU-06-VINJ001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.